IMAGIN MEDICAL INC. (DPD3) - Net Assets

Latest as of : €- EUR ≈ $- USD

Based on the latest financial reports, IMAGIN MEDICAL INC. (DPD3) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read IMAGIN MEDICAL INC. (DPD3) financial obligations for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

IMAGIN MEDICAL INC. - Net Assets Trend (2021–2022)

This chart illustrates how IMAGIN MEDICAL INC.'s net assets have evolved over time, based on quarterly financial data. Also explore DPD3 current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for IMAGIN MEDICAL INC. (2021–2022)

The table below shows the annual net assets of IMAGIN MEDICAL INC. from 2021 to 2022. For live valuation and market cap data, see market value of IMAGIN MEDICAL INC..

Year Net Assets Change
2022-09-30 €-13.34 Million
≈ $-15.59 Million
-15.55%
2021-09-30 €-11.54 Million
≈ $-13.49 Million
--

Equity Component Analysis

This analysis shows how different components contribute to IMAGIN MEDICAL INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 249220700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2022)

Component Amount Percentage
Other Components €21.28 Million %
Total Equity €-13.34 Million 100.00%

IMAGIN MEDICAL INC. Competitors by Market Cap

The table below lists competitors of IMAGIN MEDICAL INC. ranked by their market capitalization.

Company Market Cap
CuChi Commercial and Industrial Developing Investment JSC
VN:CCI
$7.00K
Grand Vision Media Holdings PLC
LSE:GVMH
$7.03K
SCG PACKAGING -FGN- BA 1
F:5Y7A
$7.06K
NewHold Investment Corp III Warrants
NASDAQ:NHICW
$7.13K
Taiwan Pelican Express Co Ltd
TW:2642
$6.23K
Enteq Upstream
LSE:NTQ
$6.19K
Norofert SA
RO:NRF
$6.13K
daVictus plc
LSE:DVT
$6.09K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IMAGIN MEDICAL INC.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from -11,540,679 to -13,335,062, a change of -1,794,383.
  • Net loss of 2,492,207 reduced equity.
  • New share issuances of 13,707 increased equity.
  • Other factors increased equity by 684,117.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income €-2.49 Million -18.69%
Share Issuances €13.71K +0.1%
Other Changes €684.12K +5.13%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares IMAGIN MEDICAL INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-09-30 €-1.25 €0.00 x
2022-09-30 €-1.23 €0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IMAGIN MEDICAL INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 0.00% 0.00% 0.00x 0.00x €-10.32 Million
2022 0.00% 0.00% 0.00x 0.00x €-1.16 Million

Industry Comparison

This section compares IMAGIN MEDICAL INC.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $934,837,026
  • Average return on equity (ROE) among peers: -23.67%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IMAGIN MEDICAL INC. (DPD3) €- 0.00% N/A $6.33K
HeraMED Limited (1I4) $2.59 Million -168.10% 0.60x $26.40 Million
Medtronic PLC (2M6) $841.50 Million 23.43% 0.53x $102.18 Billion
Peijia Medical Limited (4WO) $2.04 Billion -11.08% 0.32x $403.65 Million
AVITA Medical Inc (51KB) $20.86 Million -118.03% 0.23x $172.49 Million
MICROPORT CARDIO.MEDTECH. (72X) $2.22 Billion -2.23% 0.20x $107.57 Million
MODULIGHT OY EO 1 (78W) $44.68 Million -10.30% 0.10x $43.97 Million
ACOTEC SCIEN.H. DL-00001 (7W3) $1.28 Billion 5.50% 0.11x $377.38 Million
LIFETECH SCI.DL-00000125 (81X) $2.53 Billion 11.56% 0.26x $893.41 Million
ORTOMA AB B (82Y) $142.72 Million -13.45% 0.13x $26.39 Million
COPLAND ROAD CAPITAL NEW (A2P) $223.54 Million 46.04% 1.19x $594.67 Million

About IMAGIN MEDICAL INC.

F:DPD3 Germany Medical Devices
Market Cap
$6.33K
€5.42K EUR
Market Cap Rank
#31322 Global
#2854 in Germany
Share Price
€0.00
Change (1 day)
+0.00%
52-Week Range
€0.00 - €0.00
All Time High
€1.23
About

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. Th… Read more